Allogene Therapeutics, Inc. Insider Transactions
Allogene Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER |
Sell | 36,744 @ $1.26 | $46.17 K | 1,276,796 | 10/21/2025 | 10/23/2025 | |
|
MESSEMER DEBORAH M.
Director |
Sell | 36,885 @ $1.42 | $52.38 K | 107,431 | 06/10/2025 | 06/12/2025 | |
|
Yoshiyama Annie
SVP, Finance |
Sell | 9,601 @ $1.41 | $13.54 K | 130,663 | 04/21/2025 | 04/23/2025 | |
|
Chang David D
CEO |
Sell | 46,668 @ $1.96 | $91.47 K | 5,276,569 | 03/14/2025 | 03/18/2025 | |
|
Beneski Benjamin Machinas
SVP, Chief Technical Officer |
Sell | 5,488 @ $1.98 | $10.84 K | 218,507 | 03/14/2025 | 03/18/2025 | |
|
MESSEMER DEBORAH M.
Director |
Sell | 13,313 @ $2.43 | $32.35 K | 144,316 | 02/18/2025 | 02/20/2025 | |
|
Douglas Earl Martin
SVP, General Counsel |
Sell | 6,404 @ $1.71 | $10.95 K | 587,848 | 02/03/2025 | 02/05/2025 | |
|
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER |
Sell | 4,361 @ $1.73 | $7.55 K | 1,301,540 | 02/03/2025 | 02/05/2025 | |
|
MOORE TIMOTHY L.
Chief Technical Officer |
Sell | 14,746 @ $1.71 | $25.22 K | 250,713 | 02/03/2025 | 02/05/2025 | |
|
Chang David D
CEO |
Sell | 46,003 @ $1.68 | $77.29 K | 5,317,237 | 02/03/2025 | 02/05/2025 | |
|
Roberts Zachary
EVP of R&D |
Sell | 18,832 @ $1.70 | $32.01 K | 643,135 | 02/03/2025 | 02/05/2025 | |
|
Roberts Zachary
EVP of R&D |
Sell | 27,199 @ $1.78 | $48.41 K | 488,054 | 01/21/2025 | 01/23/2025 | |
|
MESSEMER DEBORAH M.
Director |
Sell | 9,136 @ $2.18 | $19.92 K | 157,629 | 12/09/2024 | 12/10/2024 | |
|
Humer Franz B
Director |
Sell | 9,221 @ $2.16 | $19.92 K | 307,507 | 12/05/2024 | 12/09/2024 | |
|
MESSEMER DEBORAH M.
Director |
Sell | 18,641 @ $2.28 | $42.49 K | 166,765 | 06/18/2024 | 06/20/2024 | |
|
Humer Franz B
Director |
Sell | 11,200 @ $2.34 | $26.18 K | 255,253 | 05/30/2024 | 06/03/2024 | |
|
Belldegrun Arie
Director |
Buy | 1,724,137 @ $2.90 | $5.00 M | 1,724,137 | 05/16/2024 | 05/20/2024 | |
|
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER |
Buy | 190 @ $3.60 | $683 | 819,590 | 01/30/2024 | 03/06/2024 | |
|
MESSEMER DEBORAH M.
Director |
Sell | 18,640 @ $2.70 | $50.32 K | 62,456 | 12/18/2023 | 12/20/2023 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Allogene Therapeutics, Inc. FAQ's
The list of insiders at Allogene Therapeutics, Inc. includes MESSEMER DEBORAH M., Roberts Zachary, Douglas Earl Martin, Parker Geoffrey M., MOORE TIMOTHY L., Chang David D, Beneski Benjamin Machinas, Yoshiyama Annie.
Insiders have sold a total of 275.38 K Allogene Therapeutics, Inc. shares in the last 12 months for a total of 468.08 K sold.
The following insiders have sold Allogene Therapeutics, Inc. shares in the last 12 months: MESSEMER DEBORAH M. ($104.64 K), Roberts Zachary ($80.43 K), Douglas Earl Martin ($10.95 K), Parker Geoffrey M. ($53.71 K), MOORE TIMOTHY L. ($25.22 K), Chang David D ($168.75 K), Beneski Benjamin Machinas ($10.84 K), Yoshiyama Annie ($13.54 K),